Erik T. Engelson is President and Chief Executive of Lucira Health, Inc.. Currently has a direct ownership of 23,282 shares of LHDX, which is worth approximately $698. The most recent transaction as insider was on Mar 03, 2023, when has been sold 634,666 shares (Common Stock) at a price of $1.06 per share, resulting in proceeds of $672,745. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K
0% 3M change
0% 12M change
Total Value Held $698

Erik T. Engelson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2023
SELL
Open market or private sale
$672,745 $1.06 p/Share
634,666 Reduced 96.46%
23,282 Common Stock
Mar 03 2023
BUY
Exercise of conversion of derivative security
$471,226 $0.82 p/Share
574,666 Added 46.62%
657,948 Common Stock
Sep 15 2022
BUY
Open market or private purchase
$36,400 $1.82 p/Share
20,000 Added 19.36%
83,282 Common Stock
Jun 16 2022
BUY
Open market or private purchase
$14,900 $1.49 p/Share
10,000 Added 13.65%
63,282 Common Stock
Mar 15 2022
BUY
Open market or private purchase
$90,000 $3.0 p/Share
30,000 Added 36.02%
53,282 Common Stock
Feb 09 2021
BUY
Conversion of derivative security
-
23,282 Added 50.0%
23,282 Common Stock
ETE

Erik T. Engelson

President and Chief Executive
Emeryville, CA

Track Institutional and Insider Activities on LHDX

Follow Lucira Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LHDX shares.

Notify only if

Insider Trading

Get notified when an Lucira Health, Inc. insider buys or sells LHDX shares.

Notify only if

News

Receive news related to Lucira Health, Inc.

Track Activities on LHDX